Suchergebnisse - "Subbiah, Vivek"

PubPharm (39)

1

Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma : A Case Series

enthalten in: Clinical lung cancer | 2023

von Fricke, J. | Wang, J. | Gallego, N. | +7

2

Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery

enthalten in: Oncoscience | 2023

von Gouda, M. | Janku, F. | Somaiah, N. | +3

3

Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma

enthalten in: Oncoscience | 2023

von Gouda, M. | Zarzour, M. | Vaporciyan, A. | +3

4

Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations : case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response

enthalten in: Journal of hematology & oncology | 2022

von Persha, H. | Kato, S. | De, P. | +4

5

Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma

enthalten in: Journal of immunotherapy and precision oncology | 2022

von DiPeri, T. | Demirhan, M. | Karp, D. | +9

6

The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary : a case series from a phase II basket trial

enthalten in: Investigational new drugs | 2021

von How, J. | Jazaeri, A. | Westin, S. | +10

7

A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies

enthalten in: OncoTargets and therapy | 2021

von Piha-Paul, S. | Dumbrava, E. | Nair, B. | +14

8

Neoadjuvant selpercatinib for advanced medullary thyroid cancer

enthalten in: Head & neck | 2021

von Jozaghi, Y. | Zafereo, M. | Williams, M. | +10

9

Dual inhibition of BRAF and mTOR in BRAFV600E -mutant pediatric, adolescent, and young adult brain tumors

enthalten in: Cold Spring Harbor molecular case studies | 2020

von Sen, S. | Tanaka, R. | Khatua, S. | +7

10

Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases

enthalten in: JCO precision oncology | 2020

von Andreev-Drakhlin, A. | Cabanillas, M. | Amini, B. | +1